5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.22▼ | 2.27▼ | 2.27▼ | 1.97▲ | 2.44▼ |
MA10 | 2.23▼ | 2.19▲ | 2.18▲ | 2.05▲ | 4.17▼ |
MA20 | 2.11▲ | 2.03▲ | 2.02▲ | 2.44▼ | 5.19▼ |
MA50 | 2.07▲ | 2.11▲ | 2.25▼ | 4.61▼ | 7.45▼ |
MA100 | 2.40▼ | 3.10▼ | 4.11▼ | 5.43▼ | 33.90▼ |
MA200 | 4.86▼ | 5.05▼ | 5.41▼ | 7.93▼ | 148.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.012▲ | 0.043▲ | 0.064▲ | 0.104▲ | -0.211▼ |
RSI | 55.626▲ | 53.535▲ | 50.968▲ | 35.944▼ | 30.604▼ |
STOCH | 43.893 | 75.877 | 79.326 | 27.245 | 2.113▼ |
WILL %R | -47.368 | -29.508 | -29.508 | -62.505 | -93.767▼ |
CCI | 5.814 | 58.770 | 68.766 | -12.557 | -102.309▼ |
Wednesday, May 15, 2024 06:00 AM
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial6 out of 6 Patients Who Completed the 12-Week Treatment Have ...
|
Tuesday, May 14, 2024 11:54 PM
TFFP stock results show that TFF Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be ...
|
Tuesday, May 14, 2024 03:04 PM
Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important New ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 2.065 | 2.38 | 2.065 | 2.20 | 153,124 |
15/05/24 | 1.9459 | 2.139 | 1.88 | 2.01 | 50,164 |
14/05/24 | 1.82 | 1.9922 | 1.7247 | 1.86 | 32,786 |
13/05/24 | 1.96 | 1.96 | 1.615 | 1.85 | 71,807 |
10/05/24 | 2.18 | 2.325 | 1.95 | 1.95 | 27,343 |
09/05/24 | 2.19 | 2.21 | 2.09 | 2.18 | 22,244 |
08/05/24 | 2.18 | 2.20 | 2.05 | 2.09 | 13,334 |
07/05/24 | 2.20 | 2.47 | 2.06 | 2.20 | 46,086 |
06/05/24 | 2.05 | 2.30 | 1.96 | 2.16 | 76,571 |
03/05/24 | 2.67 | 2.67 | 2.01 | 2.03 | 85,519 |
|
|
||||
|
|
||||
|
|